PDCI & H3 Survey on Private Payer Product Listing Agreements Interest, Experience & Expectations
Private payers – the community of insurers, ... Read More
Events
24
Jun2015
23
Jun2015
Australia’s Pharmaceutical Benefits Advisory Committee Recommends Substitution of Biosimilars
/ News, What's New
Currently in Canada, switching and substitutability between originator biologics and biosimilars has not been established, however that is not the ... Read More
19
Jun2015
INESSS is offering an opportunity for in-person meetings to manufacturers who have filed a submission by the deadline for drugs ... Read More
12
Jun2015
The Minister of Health and Social Services has authorized three updates to the List of Medications covered by the basic ... Read More
27
May2015
The BC Ministry of Health recently wrote to manufacturers to communicate updates to its drug review process and reimbursement submission ... Read More
27
May2015
The Ontario Public Drug Programs Division (OPDP) recently announced amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit ... Read More
25
May2015
The Canadian Organization for Rare Disorders (CORD) announced Friday that it will help launch Canada's first ever Rare Disease Strategy ... Read More
10
Apr2015
PDCI Presentation at Women In Bio (Montreal Chapter) – April 16th, 2015... Read More